Author

Lijuan Yang

National Institutes of HealthORCID 0000-0002-7212-7110Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lijuan Yang1 paper · National Institutes of Health

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Celia P. SantosiD· 1 shared Cindy LuongoiD· 1 shared Cyril Le NouëniD· 1 shared Eleanor F Duncan· 1 shared Hong-Su ParkiD· 1 shared I‐Ting TengiD· 1 shared Jaclyn A. Kaiser· 1 shared Peter D. KwongiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Celia P. SantosORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge

Hong-Su Park, Yumiko Matsuoka, Celia P. Santos, Cindy Luongo, Xueqiao Liu, Lijuan Yang, Jaclyn A. Kaiser, Eleanor F Duncan, Reed F. Johnson, I‐Ting Teng, Peter D. Kwong, Ursula J. Buchholz, Cyril Le Nouën

This study evaluates intranasal B/HPIV3 vaccines expressing SARS-CoV-2 spike proteins of different variants, showing they induce mucosal and systemic immunity and protect hamsters against homologous and heterologous challenges.

PLoS Pathogens · Apr 21, 2025Peer-reviewedMicrobiology